Biochemical recurrent ovarian cancer: CA 125 elevation without symptoms or clinical evidence of disease. What is the optimal management?

Emily Berry*, Jean A. Hurteau

*Corresponding author for this work

Research output: Contribution to journalEditorialpeer-review

Original languageEnglish (US)
Pages (from-to)1-5
Number of pages5
JournalWomen's Oncology Review
Issue number1-2
StatePublished - Mar 2006

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynecology
  • Cancer Research

Cite this